Management tracks

Antibody company Prothena Corp. plc (NASDAQ:PRTA) said President and CEO Dale Schenk is taking a medical leave of absence. He will remain on Prothena's board. COO Gene Kinney will lead the company

Read the full 323 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE